These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23454532)

  • 1. Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones.
    Al-Omary FA; Hassan GS; El-Messery SM; Nagi MN; Habib el-SE; El-Subbagh HI
    Eur J Med Chem; 2013 May; 63():33-45. PubMed ID: 23454532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-classical antifolates. Part 2: synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones.
    Al-Omary FA; Abou-Zeid LA; Nagi MN; Habib el-SE; Abdel-Aziz AA; El-Azab AS; Abdel-Hamide SG; Al-Omar MA; Al-Obaid AM; El-Subbagh HI
    Bioorg Med Chem; 2010 Apr; 18(8):2849-63. PubMed ID: 20350811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolyl-thio and 4-methyl-thiazolyl-thio)-quinazolin-4-ones as a new class of DHFR inhibitors.
    Al-Rashood ST; Hassan GS; El-Messery SM; Nagi MN; Habib EE; Al-Omary FAM; El-Subbagh HI
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4557-4567. PubMed ID: 25139568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation and molecular modeling study of some new methoxylated 2-benzylthio-quinazoline-4(3H)-ones as nonclassical antifolates.
    El-Messery SM; Hassan GS; Nagi MN; Habib EE; Al-Rashood ST; El-Subbagh HI
    Bioorg Med Chem Lett; 2016 Oct; 26(19):4815-4823. PubMed ID: 27554444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological evaluation and molecular modeling study of new (1,2,4-triazole or 1,3,4-thiadiazole)-methylthio-derivatives of quinazolin-4(3H)-one as DHFR inhibitors.
    El-Gazzar YI; Georgey HH; El-Messery SM; Ewida HA; Hassan GS; Raafat MM; Ewida MA; El-Subbagh HI
    Bioorg Chem; 2017 Jun; 72():282-292. PubMed ID: 28499189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonclassical antifolates, part 4. 5-(2-aminothiazol-4-yl)-4-phenyl-4H-1,2,4-triazole-3-thiols as a new class of DHFR inhibitors: synthesis, biological evaluation and molecular modeling study.
    Hassan GS; El-Messery SM; Al-Omary FA; Al-Rashood ST; Shabayek MI; Abulfadl YS; Habib el-SE; El-Hallouty SM; Fayad W; Mohamed KM; El-Menshawi BS; El-Subbagh HI
    Eur J Med Chem; 2013 Aug; 66():135-45. PubMed ID: 23792351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs.
    Al-Rashood ST; Aboldahab IA; Nagi MN; Abouzeid LA; Abdel-Aziz AA; Abdel-Hamide SG; Youssef KM; Al-Obaid AM; El-Subbagh HI
    Bioorg Med Chem; 2006 Dec; 14(24):8608-21. PubMed ID: 16971132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antimicrobial activity of novel 5-amino-4-cyano-1H-pyrazole and quinazolin-4(3H)-one derivatives.
    Abdel-Aal MT; Abdel-Aleem AA; Ibahim LI; Zein AL
    Arch Pharm Res; 2010 Dec; 33(12):1891-900. PubMed ID: 21191752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazolo[4,5-d]pyridazine analogues as a new class of dihydrofolate reductase (DHFR) inhibitors: Synthesis, biological evaluation and molecular modeling study.
    Ewida MA; Abou El Ella DA; Lasheen DS; Ewida HA; El-Gazzar YI; El-Subbagh HI
    Bioorg Chem; 2017 Oct; 74():228-237. PubMed ID: 28865294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.
    Gangjee A; Vidwans AP; Vasudevan A; Queener SF; Kisliuk RL; Cody V; Li R; Galitsky N; Luft JR; Pangborn W
    J Med Chem; 1998 Aug; 41(18):3426-34. PubMed ID: 9719595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, antitumor testing and molecular modeling study of some new 6-substituted amido, azo or thioureido-quinazolin-4(3H)-ones.
    Sabry MA; Ewida HA; Hassan GS; Ghaly MA; El-Subbagh HI
    Bioorg Chem; 2019 Jul; 88():102923. PubMed ID: 30991189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumor activity of some 2, 3-disubstituted quinazolin-4(3H)-ones and 4, 6- disubstituted- 1, 2, 3, 4-tetrahydroquinazolin-2H-ones.
    Abdel Gawad NM; Georgey HH; Youssef RM; El-Sayed NA
    Eur J Med Chem; 2010 Dec; 45(12):6058-67. PubMed ID: 21051122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antileishmanial and antimicrobial activities of some 2,3-disubstituted 3H-quinazolin-4-ones.
    Arfan M; Khan R; Khan MA; Anjum S; Choudhary MI; Ahmad M
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):451-8. PubMed ID: 20235747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents.
    Gangjee A; Adair OO; Queener SF
    J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and evaluation of antitumor acylated monoaminopyrroloquinazolines.
    Chao B; Li BX; Xiao X
    Bioorg Med Chem Lett; 2017 Jul; 27(14):3107-3110. PubMed ID: 28552339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,4-diamino-5-deaza-6-substituted pyrido[2,3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases.
    Gangjee A; Vasudevan A; Queener SF; Kisliuk RL
    J Med Chem; 1996 Mar; 39(7):1438-46. PubMed ID: 8691474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting dihydrofolate reductase: Design, synthesis and biological evaluation of novel 6-substituted pyrrolo[2,3-d]pyrimidines as nonclassical antifolates and as potential antitumor agents.
    Gao T; Zhang C; Shi X; Guo R; Zhang K; Gu J; Li L; Li S; Zheng Q; Cui M; Cui M; Gao X; Liu Y; Wang L
    Eur J Med Chem; 2019 Sep; 178():329-340. PubMed ID: 31200235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New quinazolinone-based derivatives as DHFR/EGFR-TK inhibitors: Synthesis, molecular modeling simulations, and anticancer activity.
    El-Gazzar YI; Ghaiad HR; El Kerdawy AM; George RF; Georgey HH; Youssef KM; El-Subbagh HI
    Arch Pharm (Weinheim); 2023 Jan; 356(1):e2200417. PubMed ID: 36257809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size.
    Kuyper LF; Baccanari DP; Jones ML; Hunter RN; Tansik RL; Joyner SS; Boytos CM; Rudolph SK; Knick V; Wilson HR; Caddell JM; Friedman HS; Comley JC; Stables JN
    J Med Chem; 1996 Feb; 39(4):892-903. PubMed ID: 8632413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of 5-alkyl modification on the biological activity of pyrrolo[2,3-d]pyrimidine containing classical and nonclassical antifolates as inhibitors of dihydrofolate reductase and as antitumor and/or antiopportunistic infection agents.
    Gangjee A; Jain HD; Queener SF; Kisliuk RL
    J Med Chem; 2008 Aug; 51(15):4589-600. PubMed ID: 18605720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.